Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for type 2 endoleak after EVAR
jRCTs041180163Completed
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of tranexamic acid in abdominal aortic aneurysm (AAA), iliac artery aneurysm (IAA) and endoleak (2 arms). Primary endpoint: Incidence of type 2 endoleak. Started May 2017; status: completed.
02
Drugs
tranexamic acid
03
Conditions
abdominal aortic aneurysm (AAA)iliac artery aneurysm (IAA)endoleak
Beyond the preview
Go deeper on jRCTs041180163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180163.